CSF1R and neoplasm: Similarly to PD-L1 blockade, pretreatment with anti-CSF1R antibody reversed Lal–/– CD11c+ MDSCs’ suppressive activity on T cells (Figure 5C) and stimulation of tumor growth (Figure 5D).